Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

XRP Faces a Supply Crunch as Institutional Demand Soars

Felix Baarz by Felix Baarz
December 11, 2025
in Analysis, Blockchain, ETF, Ethereum & Altcoins, Trading & Momentum
0
XRP Stock
0
SHARES
30
VIEWS
Share on FacebookShare on Twitter

At first glance, XRP appears to be struggling, trading well below its yearly peak. However, this corrective facade masks a significant underlying shift. As price action stalls, substantial movements are occurring behind the scenes: exchange-traded funds (ETFs) and major investors are rapidly draining available supply, causing exchange reserves to plummet. This stark divergence between weak technicals and powerful on-chain fundamentals suggests a major directional move is imminent.

Institutional Accumulation Reaches a Fever Pitch

The primary reason for analyst optimism, despite the lackluster price chart, is unprecedented institutional demand. Since their launch in mid-November, spot XRP ETFs have attracted capital at a pace that even surpasses the early days of Bitcoin and Ethereum ETF products.

  • Approaching $1 Billion: Net inflows are nearing the $1 billion threshold, currently standing at approximately $944 million.
  • Unbroken Inflow Streak: These funds have recorded 15 consecutive days of inflows, completely disregarding the sideways price movement.
  • Direct Market Impact: These investment vehicles alone have already absorbed more than 500 million XRP tokens from the freely traded market.

Exchange Reserves Plummet

This aggressive accumulation is triggering a dramatic contraction in readily available supply. Data from Glassnode confirms that XRP holdings on centralized exchanges have collapsed by 45% over the past two months. In the last three weeks alone, over one billion tokens have been withdrawn from trading platforms—a classic indicator that investors are moving assets into long-term storage.

A massive redistribution of tokens is occurring simultaneously. While smaller retail investors sell, large-scale holders are buying. Wallets containing between 10 million and 100 million XRP acquired holdings worth over $700 million in just four days.

Should investors sell immediately? Or is it worth buying XRP?

Technical Vulnerabilities and Support Test

From a purely technical perspective, XRP is navigating a precarious phase. The asset is currently priced at $2.05, testing a critical support band between $2.00 and $2.02. A decisive break below this level could trigger further selling pressure, especially given that annualized volatility remains elevated above 53%.

Derivatives data paints a risky picture. Funding rates have recently spiked, signaling a high concentration of leveraged bets anticipating higher prices. Should the $2.00 support fail, a “long squeeze” forcing the liquidation of these positions becomes a tangible threat. However, with a Relative Strength Index (RSI) reading of 28.8, the market is already technically oversold, which may limit the potential for further downside.

Regulatory Tailwinds and Market Outlook

The broader market environment is providing additional support. The U.S. Office of the Comptroller of the Currency (OCC) recently criticized what it called “politically motivated” account closures for crypto firms by banks, a move that strengthens the sector. Furthermore, Bitnomial has launched XRP trading, becoming the first CFTC-regulated exchange to do so.

The market structure is now clearly defined. Short-term technical risks around the $2.00 level are colliding with a fundamental supply shock. Once the current consolidation phase concludes and the market digests the upcoming U.S. Federal Reserve interest rate decision, the severe imbalance between depleted exchange inventories and relentless ETF demand is likely to dictate the next major trend.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from February 7 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

XRP: Buy or sell? Read more here...

Tags: XRP
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Next Post
Ballard Power Stock

Ballard Power: A Cautious Market Appraises Operational Gains

Nel ASA Stock

Nel ASA Strengthens Project Leadership Amid Strong Order Intake

Gold Stock

Gold Nears Record Territory as Central Bank Moves and Demand Converge

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com